CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on the unaudited financial results for the quarter ended on June 30, 2021.11-08-2021
11-08-2021
Cadila Healthcare Ltd - 532321 - Intimation Of Unaudited Results For The Quarter Ended On June 30, 2021.
Intimation of unaudited results for the quarter ended on June 30, 2021.11-08-2021
Zydus Cadila COVID-19 vaccine to get emergency use approval this week: Report
Zydus Cadila's jab will be the sixth COVID-19 vaccine to get approved in India after Covishield, Covaxin, Sputnik V, Moderna and JJ.10-08-2021
India Covid Dispatch: Zydus Cadila's vaccine may get the nod soon
28% people in TN above 60 yrs show vaccine hesitancy, fully vaccinated people can commute by Mumbai locals from Aug 15 and other stories from around the country on the fight against the pandemic09-08-2021
Cadila Healthcare Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate09-08-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post results Q&A; session through teleconference has been scheduled on August 11, 2021 at 4:00 pm.06-08-2021
Cadila Healthcare Ltd - 532321 - Board Meeting Intimation for June 2021 Unaudited Financial Results
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve June 2021 unaudited financial results03-08-2021
Zydus Cadila gets USFDA nod for breast cancer treatment drug
Fulvestrant injection is used alone or in combination with other drugs to treat a certain type of hormone receptor positive, advanced breast cancer (breast cancer that depends on hormones such as estrogen to grow) or breast cancer that has spread to other parts of the body in women who have experienced menopause.30-07-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release dated titled 'Zydus Cadila receives final approval from USFDA for Fulvestrant Injection30-07-2021
India may soon have Covid-19 vaccines for children. All you need to know
Zydus Cadila DNA-plasmid vaccine is the prime contender. It has held trials on children aged 12 years and above29-07-2021